Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
BeiGene Ltd ( (HK:6160) ) has shared an announcement.
BeOne Medicines Ltd., a Swiss corporation listed on the Hong Kong Stock Exchange, has announced the grant of 36,510 Restricted Share Units (RSUs) to 202 employees under its 2016 Share Option and Incentive Plan. This grant represents approximately 0.03% of the company’s total issued shares. The RSUs are set to vest over four years, with no performance targets or clawback mechanisms attached, aligning with the company’s customary practices and market competitiveness. This move reflects the company’s strategy to incentivize its workforce while maintaining flexibility in its employee compensation structure.
The most recent analyst rating on (HK:6160) stock is a Hold with a HK$200.00 price target. To see the full list of analyst forecasts on BeiGene Ltd stock, see the HK:6160 Stock Forecast page.
More about BeiGene Ltd
Average Trading Volume: 6,485,762
Technical Sentiment Signal: Buy
Current Market Cap: HK$329.8B
Learn more about 6160 stock on TipRanks’ Stock Analysis page.